Nivolumab alone and with ipilimumab in previously treated metastatic urothelial carcinoma: CheckMate 032 nivolumab 1 mg/kg plus ipilimumab 3 mg/kg expansion cohort results.
Journal of Clinical Oncology.
Times cited: 6
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer.
World Journal of Urology.
Times cited: 3
Frequent truncating mutations of STAG2 in bladder cancer.
Times cited: 108